ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intelligent Clinical Trials Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-12M14056
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Intelligent Clinical Trials Market Research Report 2023
BUY CHAPTERS

Global Intelligent Clinical Trials Market Research Report 2025

Code: QYRE-Auto-12M14056
Report
May 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Cerner Corporation
GE Healthcare
Koninklijke Philips N V
Cognizant
McKesson Corporation
Athenahealth
Navitas Life Sciences
Accenture Plc
Veradigm
Medidata Acorn AI

Intelligent Clinical Trials Market

The global market for Intelligent Clinical Trials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Artificial intelligence can reduce clinical trial cycle times while improving the costs of productivity and outcomes of clinical development.
Global Intelligent Clinical Trials Market
The global intelligent clinical trials market refers to the market for advanced technologies and solutions that streamline and optimize the clinical trial processes. Intelligent clinical trials utilize innovative technologies, data analytics, and automation to enhance efficiency, reduce costs, improve patient recruitment and retention, and accelerate the drug development process.
Here are key aspects and components within the global intelligent clinical trials market:
Technology and Solutions: The market encompasses a wide range of technologies and solutions that revolutionize different stages of the clinical trial process. This includes electronic data capture (EDC) systems, electronic patient-reported outcomes (ePRO) platforms, remote monitoring tools, real-time data analytics, predictive analytics, artificial intelligence (AI), machine learning (ML), wearables, cloud computing, and blockchain technology. These technologies enable seamless data collection, analysis, and integration, enhancing the overall trial management and decision-making process.
Benefits and Advantages: Intelligent clinical trials offer numerous benefits over traditional methods, driving the market growth. These benefits include enhanced patient engagement and experience, improved trial design and protocols, optimized recruitment and retention strategies, real-time monitoring of patient safety data, faster data analysis and insights, reduced human errors, efficient site selection and management, better regulatory compliance, and overall cost and time savings in drug development.
Remote and Decentralized Trials: With the COVID-19 pandemic, there has been a significant shift towards remote and decentralized clinical trials. Intelligent solutions enable remote data collection, virtual patient visits, and monitoring, eliminating the need for patients to visit physical sites regularly. This approach improves patient convenience, expands geographic reach, increases patient participation, and reduces trial costs. Intelligent technologies facilitate remote patient monitoring, virtual site visits, and secure data transmission for decentralized trials.
Data Integration and Analytics: Intelligent clinical trials emphasize the integration and analysis of various data sources to derive meaningful insights. Advanced analytics and AI/ML algorithms help analyze vast amounts of clinical data, patient records, genetics, and real-world evidence to identify patterns, optimize trial outcomes, and predict patient responses. Real-time data analytics enable adaptive trial design, dynamic patient cohort identification, and rapid decision-making based on evolving trial data.
Regulatory Landscape and Standards: The market is influenced by regulatory frameworks and standards governing clinical trials globally. Regulatory bodies are increasingly recognizing the benefits of intelligent clinical trial technologies in improving trial efficiency and data quality. Efforts are being made to establish guidelines, data standards (such as CDISC), and cybersecurity regulations to ensure data integrity, patient privacy, and compliance during the implementation of intelligent solutions.
Collaboration and Partnerships: The intelligent clinical trials market involves collaborations between pharmaceutical companies, contract research organizations (CROs), technology providers, academic institutions, and healthcare providers. These collaborations aim to leverage domain expertise, technological capabilities, and data-sharing initiatives to develop and implement intelligent solutions effectively. Partnerships between technology providers and CROs help in the adoption of intelligent tools and platforms across the clinical trial ecosystem.
Market Dynamics: The market for intelligent clinical trials is driven by factors such as the increasing complexity and cost of traditional trials, the need for faster drug development, rising patient-centric approaches, advancements in digital health technologies, and the growing power of data analytics and AI. Additionally, the COVID-19 pandemic has accelerated the adoption of remote and decentralized trial models, further fueling the demand for intelligent solutions.
The global intelligent clinical trials market presents opportunities for technology providers to develop innovative solutions, expand their product portfolios, and enter strategic partnerships with pharmaceutical companies and CROs. However, challenges such as data privacy and security concerns, regulatory compliance, infrastructure limitations, and the need for skilled personnel in implementing intelligent technologies remain significant in the market.
Overall, the intelligent clinical trials market is driven by the increasing demand for efficient and patient-centric drug development processes and the integration of advanced technologies and data analytics to optimize trial outcomes. The market is poised for significant growth as pharmaceutical companies and research organizations embrace intelligent solutions to transform the clinical trial landscape.Global Intelligent Clinical Trials Market
The global intelligent clinical trials market refers to the market for advanced technologies and solutions that streamline and optimize the clinical trial processes. Intelligent clinical trials utilize innovative technologies, data analytics, and automation to enhance efficiency, reduce costs, improve patient recruitment and retention, and accelerate the drug development process.
Here are key aspects and components within the global intelligent clinical trials market:
Technology and Solutions: The market encompasses a wide range of technologies and solutions that revolutionize different stages of the clinical trial process. This includes electronic data capture (EDC) systems, electronic patient-reported outcomes (ePRO) platforms, remote monitoring tools, real-time data analytics, predictive analytics, artificial intelligence (AI), machine learning (ML), wearables, cloud computing, and blockchain technology. These technologies enable seamless data collection, analysis, and integration, enhancing the overall trial management and decision-making process.
Benefits and Advantages: Intelligent clinical trials offer numerous benefits over traditional methods, driving the market growth. These benefits include enhanced patient engagement and experience, improved trial design and protocols, optimized recruitment and retention strategies, real-time monitoring of patient safety data, faster data analysis and insights, reduced human errors, efficient site selection and management, better regulatory compliance, and overall cost and time savings in drug development.
Remote and Decentralized Trials: With the COVID-19 pandemic, there has been a significant shift towards remote and decentralized clinical trials. Intelligent solutions enable remote data collection, virtual patient visits, and monitoring, eliminating the need for patients to visit physical sites regularly. This approach improves patient convenience, expands geographic reach, increases patient participation, and reduces trial costs. Intelligent technologies facilitate remote patient monitoring, virtual site visits, and secure data transmission for decentralized trials.
Data Integration and Analytics: Intelligent clinical trials emphasize the integration and analysis of various data sources to derive meaningful insights. Advanced analytics and AI/ML algorithms help analyze vast amounts of clinical data, patient records, genetics, and real-world evidence to identify patterns, optimize trial outcomes, and predict patient responses. Real-time data analytics enable adaptive trial design, dynamic patient cohort identification, and rapid decision-making based on evolving trial data.
Regulatory Landscape and Standards: The market is influenced by regulatory frameworks and standards governing clinical trials globally. Regulatory bodies are increasingly recognizing the benefits of intelligent clinical trial technologies in improving trial efficiency and data quality. Efforts are being made to establish guidelines, data standards (such as CDISC), and cybersecurity regulations to ensure data integrity, patient privacy, and compliance during the implementation of intelligent solutions.
Collaboration and Partnerships: The intelligent clinical trials market involves collaborations between pharmaceutical companies, contract research organizations (CROs), technology providers, academic institutions, and healthcare providers. These collaborations aim to leverage domain expertise, technological capabilities, and data-sharing initiatives to develop and implement intelligent solutions effectively. Partnerships between technology providers and CROs help in the adoption of intelligent tools and platforms across the clinical trial ecosystem.
Market Dynamics: The market for intelligent clinical trials is driven by factors such as the increasing complexity and cost of traditional trials, the need for faster drug development, rising patient-centric approaches, advancements in digital health technologies, and the growing power of data analytics and AI. Additionally, the COVID-19 pandemic has accelerated the adoption of remote and decentralized trial models, further fueling the demand for intelligent solutions.
The global intelligent clinical trials market presents opportunities for technology providers to develop innovative solutions, expand their product portfolios, and enter strategic partnerships with pharmaceutical companies and CROs. However, challenges such as data privacy and security concerns, regulatory compliance, infrastructure limitations, and the need for skilled personnel in implementing intelligent technologies remain significant in the market.
Overall, the intelligent clinical trials market is driven by the increasing demand for efficient and patient-centric drug development processes and the integration of advanced technologies and data analytics to optimize trial outcomes. The market is poised for significant growth as pharmaceutical companies and research organizations embrace intelligent solutions to transform the clinical trial landscape.
This report aims to provide a comprehensive presentation of the global market for Intelligent Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intelligent Clinical Trials.
The Intelligent Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intelligent Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intelligent Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Intelligent Clinical Trials Market Report

Report Metric Details
Report Name Intelligent Clinical Trials Market
Segment by Type
  • Interventional
  • Observational
  • Expanded Access
  • Others
Segment by Application
  • Autoimmune/Inflammation
  • Pain Management
  • Oncology
  • Central Nervous System (CNS) Condition
  • Diabetes
  • Obesity
  • Cardiovascular
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cerner Corporation, GE Healthcare, Koninklijke Philips N.V., Cognizant, McKesson Corporation, Athenahealth, Veradigm, Navitas Life Sciences, Medidata Acorn AI, Accenture
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Intelligent Clinical Trials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Intelligent Clinical Trials Market report?

Ans: The main players in the Intelligent Clinical Trials Market are Cerner Corporation, GE Healthcare, Koninklijke Philips N.V., Cognizant, McKesson Corporation, Athenahealth, Veradigm, Navitas Life Sciences, Medidata Acorn AI, Accenture

What are the Application segmentation covered in the Intelligent Clinical Trials Market report?

Ans: The Applications covered in the Intelligent Clinical Trials Market report are Autoimmune/Inflammation, Pain Management, Oncology, Central Nervous System (CNS) Condition, Diabetes, Obesity, Cardiovascular, Others

What are the Type segmentation covered in the Intelligent Clinical Trials Market report?

Ans: The Types covered in the Intelligent Clinical Trials Market report are Interventional, Observational, Expanded Access, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intelligent Clinical Trials Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Interventional
1.2.3 Observational
1.2.4 Expanded Access
1.2.5 Others
1.3 Market by Application
1.3.1 Global Intelligent Clinical Trials Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Autoimmune/Inflammation
1.3.3 Pain Management
1.3.4 Oncology
1.3.5 Central Nervous System (CNS) Condition
1.3.6 Diabetes
1.3.7 Obesity
1.3.8 Cardiovascular
1.3.9 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intelligent Clinical Trials Market Perspective (2020-2031)
2.2 Global Intelligent Clinical Trials Growth Trends by Region
2.2.1 Global Intelligent Clinical Trials Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Intelligent Clinical Trials Historic Market Size by Region (2020-2025)
2.2.3 Intelligent Clinical Trials Forecasted Market Size by Region (2026-2031)
2.3 Intelligent Clinical Trials Market Dynamics
2.3.1 Intelligent Clinical Trials Industry Trends
2.3.2 Intelligent Clinical Trials Market Drivers
2.3.3 Intelligent Clinical Trials Market Challenges
2.3.4 Intelligent Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intelligent Clinical Trials Players by Revenue
3.1.1 Global Top Intelligent Clinical Trials Players by Revenue (2020-2025)
3.1.2 Global Intelligent Clinical Trials Revenue Market Share by Players (2020-2025)
3.2 Global Intelligent Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Intelligent Clinical Trials Revenue
3.4 Global Intelligent Clinical Trials Market Concentration Ratio
3.4.1 Global Intelligent Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intelligent Clinical Trials Revenue in 2024
3.5 Global Key Players of Intelligent Clinical Trials Head office and Area Served
3.6 Global Key Players of Intelligent Clinical Trials, Product and Application
3.7 Global Key Players of Intelligent Clinical Trials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Intelligent Clinical Trials Breakdown Data by Type
4.1 Global Intelligent Clinical Trials Historic Market Size by Type (2020-2025)
4.2 Global Intelligent Clinical Trials Forecasted Market Size by Type (2026-2031)
5 Intelligent Clinical Trials Breakdown Data by Application
5.1 Global Intelligent Clinical Trials Historic Market Size by Application (2020-2025)
5.2 Global Intelligent Clinical Trials Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Intelligent Clinical Trials Market Size (2020-2031)
6.2 North America Intelligent Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Intelligent Clinical Trials Market Size by Country (2020-2025)
6.4 North America Intelligent Clinical Trials Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intelligent Clinical Trials Market Size (2020-2031)
7.2 Europe Intelligent Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Intelligent Clinical Trials Market Size by Country (2020-2025)
7.4 Europe Intelligent Clinical Trials Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intelligent Clinical Trials Market Size (2020-2031)
8.2 Asia-Pacific Intelligent Clinical Trials Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Intelligent Clinical Trials Market Size by Region (2020-2025)
8.4 Asia-Pacific Intelligent Clinical Trials Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intelligent Clinical Trials Market Size (2020-2031)
9.2 Latin America Intelligent Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Intelligent Clinical Trials Market Size by Country (2020-2025)
9.4 Latin America Intelligent Clinical Trials Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intelligent Clinical Trials Market Size (2020-2031)
10.2 Middle East & Africa Intelligent Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Intelligent Clinical Trials Market Size by Country (2020-2025)
10.4 Middle East & Africa Intelligent Clinical Trials Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cerner Corporation
11.1.1 Cerner Corporation Company Details
11.1.2 Cerner Corporation Business Overview
11.1.3 Cerner Corporation Intelligent Clinical Trials Introduction
11.1.4 Cerner Corporation Revenue in Intelligent Clinical Trials Business (2020-2025)
11.1.5 Cerner Corporation Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Intelligent Clinical Trials Introduction
11.2.4 GE Healthcare Revenue in Intelligent Clinical Trials Business (2020-2025)
11.2.5 GE Healthcare Recent Development
11.3 Koninklijke Philips N.V.
11.3.1 Koninklijke Philips N.V. Company Details
11.3.2 Koninklijke Philips N.V. Business Overview
11.3.3 Koninklijke Philips N.V. Intelligent Clinical Trials Introduction
11.3.4 Koninklijke Philips N.V. Revenue in Intelligent Clinical Trials Business (2020-2025)
11.3.5 Koninklijke Philips N.V. Recent Development
11.4 Cognizant
11.4.1 Cognizant Company Details
11.4.2 Cognizant Business Overview
11.4.3 Cognizant Intelligent Clinical Trials Introduction
11.4.4 Cognizant Revenue in Intelligent Clinical Trials Business (2020-2025)
11.4.5 Cognizant Recent Development
11.5 McKesson Corporation
11.5.1 McKesson Corporation Company Details
11.5.2 McKesson Corporation Business Overview
11.5.3 McKesson Corporation Intelligent Clinical Trials Introduction
11.5.4 McKesson Corporation Revenue in Intelligent Clinical Trials Business (2020-2025)
11.5.5 McKesson Corporation Recent Development
11.6 Athenahealth
11.6.1 Athenahealth Company Details
11.6.2 Athenahealth Business Overview
11.6.3 Athenahealth Intelligent Clinical Trials Introduction
11.6.4 Athenahealth Revenue in Intelligent Clinical Trials Business (2020-2025)
11.6.5 Athenahealth Recent Development
11.7 Veradigm
11.7.1 Veradigm Company Details
11.7.2 Veradigm Business Overview
11.7.3 Veradigm Intelligent Clinical Trials Introduction
11.7.4 Veradigm Revenue in Intelligent Clinical Trials Business (2020-2025)
11.7.5 Veradigm Recent Development
11.8 Navitas Life Sciences
11.8.1 Navitas Life Sciences Company Details
11.8.2 Navitas Life Sciences Business Overview
11.8.3 Navitas Life Sciences Intelligent Clinical Trials Introduction
11.8.4 Navitas Life Sciences Revenue in Intelligent Clinical Trials Business (2020-2025)
11.8.5 Navitas Life Sciences Recent Development
11.9 Medidata Acorn AI
11.9.1 Medidata Acorn AI Company Details
11.9.2 Medidata Acorn AI Business Overview
11.9.3 Medidata Acorn AI Intelligent Clinical Trials Introduction
11.9.4 Medidata Acorn AI Revenue in Intelligent Clinical Trials Business (2020-2025)
11.9.5 Medidata Acorn AI Recent Development
11.10 Accenture
11.10.1 Accenture Company Details
11.10.2 Accenture Business Overview
11.10.3 Accenture Intelligent Clinical Trials Introduction
11.10.4 Accenture Revenue in Intelligent Clinical Trials Business (2020-2025)
11.10.5 Accenture Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Cerner Corporation
GE Healthcare
Koninklijke Philips N V
Cognizant
McKesson Corporation
Athenahealth
Navitas Life Sciences
Accenture Plc
Veradigm
Medidata Acorn AI
List of Tables
 Table 1. Global Intelligent Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Interventional
 Table 3. Key Players of Observational
 Table 4. Key Players of Expanded Access
 Table 5. Key Players of Others
 Table 6. Global Intelligent Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Intelligent Clinical Trials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Intelligent Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Intelligent Clinical Trials Market Share by Region (2020-2025)
 Table 10. Global Intelligent Clinical Trials Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Intelligent Clinical Trials Market Share by Region (2026-2031)
 Table 12. Intelligent Clinical Trials Market Trends
 Table 13. Intelligent Clinical Trials Market Drivers
 Table 14. Intelligent Clinical Trials Market Challenges
 Table 15. Intelligent Clinical Trials Market Restraints
 Table 16. Global Intelligent Clinical Trials Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Intelligent Clinical Trials Market Share by Players (2020-2025)
 Table 18. Global Top Intelligent Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intelligent Clinical Trials as of 2024)
 Table 19. Ranking of Global Top Intelligent Clinical Trials Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Intelligent Clinical Trials Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Intelligent Clinical Trials, Headquarters and Area Served
 Table 22. Global Key Players of Intelligent Clinical Trials, Product and Application
 Table 23. Global Key Players of Intelligent Clinical Trials, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Intelligent Clinical Trials Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Intelligent Clinical Trials Revenue Market Share by Type (2020-2025)
 Table 27. Global Intelligent Clinical Trials Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Intelligent Clinical Trials Revenue Market Share by Type (2026-2031)
 Table 29. Global Intelligent Clinical Trials Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Intelligent Clinical Trials Revenue Market Share by Application (2020-2025)
 Table 31. Global Intelligent Clinical Trials Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Intelligent Clinical Trials Revenue Market Share by Application (2026-2031)
 Table 33. North America Intelligent Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Intelligent Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Intelligent Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Intelligent Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Intelligent Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Intelligent Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Intelligent Clinical Trials Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Intelligent Clinical Trials Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Intelligent Clinical Trials Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Intelligent Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Intelligent Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intelligent Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Intelligent Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Intelligent Clinical Trials Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Intelligent Clinical Trials Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Cerner Corporation Company Details
 Table 49. Cerner Corporation Business Overview
 Table 50. Cerner Corporation Intelligent Clinical Trials Product
 Table 51. Cerner Corporation Revenue in Intelligent Clinical Trials Business (2020-2025) & (US$ Million)
 Table 52. Cerner Corporation Recent Development
 Table 53. GE Healthcare Company Details
 Table 54. GE Healthcare Business Overview
 Table 55. GE Healthcare Intelligent Clinical Trials Product
 Table 56. GE Healthcare Revenue in Intelligent Clinical Trials Business (2020-2025) & (US$ Million)
 Table 57. GE Healthcare Recent Development
 Table 58. Koninklijke Philips N.V. Company Details
 Table 59. Koninklijke Philips N.V. Business Overview
 Table 60. Koninklijke Philips N.V. Intelligent Clinical Trials Product
 Table 61. Koninklijke Philips N.V. Revenue in Intelligent Clinical Trials Business (2020-2025) & (US$ Million)
 Table 62. Koninklijke Philips N.V. Recent Development
 Table 63. Cognizant Company Details
 Table 64. Cognizant Business Overview
 Table 65. Cognizant Intelligent Clinical Trials Product
 Table 66. Cognizant Revenue in Intelligent Clinical Trials Business (2020-2025) & (US$ Million)
 Table 67. Cognizant Recent Development
 Table 68. McKesson Corporation Company Details
 Table 69. McKesson Corporation Business Overview
 Table 70. McKesson Corporation Intelligent Clinical Trials Product
 Table 71. McKesson Corporation Revenue in Intelligent Clinical Trials Business (2020-2025) & (US$ Million)
 Table 72. McKesson Corporation Recent Development
 Table 73. Athenahealth Company Details
 Table 74. Athenahealth Business Overview
 Table 75. Athenahealth Intelligent Clinical Trials Product
 Table 76. Athenahealth Revenue in Intelligent Clinical Trials Business (2020-2025) & (US$ Million)
 Table 77. Athenahealth Recent Development
 Table 78. Veradigm Company Details
 Table 79. Veradigm Business Overview
 Table 80. Veradigm Intelligent Clinical Trials Product
 Table 81. Veradigm Revenue in Intelligent Clinical Trials Business (2020-2025) & (US$ Million)
 Table 82. Veradigm Recent Development
 Table 83. Navitas Life Sciences Company Details
 Table 84. Navitas Life Sciences Business Overview
 Table 85. Navitas Life Sciences Intelligent Clinical Trials Product
 Table 86. Navitas Life Sciences Revenue in Intelligent Clinical Trials Business (2020-2025) & (US$ Million)
 Table 87. Navitas Life Sciences Recent Development
 Table 88. Medidata Acorn AI Company Details
 Table 89. Medidata Acorn AI Business Overview
 Table 90. Medidata Acorn AI Intelligent Clinical Trials Product
 Table 91. Medidata Acorn AI Revenue in Intelligent Clinical Trials Business (2020-2025) & (US$ Million)
 Table 92. Medidata Acorn AI Recent Development
 Table 93. Accenture Company Details
 Table 94. Accenture Business Overview
 Table 95. Accenture Intelligent Clinical Trials Product
 Table 96. Accenture Revenue in Intelligent Clinical Trials Business (2020-2025) & (US$ Million)
 Table 97. Accenture Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Intelligent Clinical Trials Picture
 Figure 2. Global Intelligent Clinical Trials Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intelligent Clinical Trials Market Share by Type: 2024 VS 2031
 Figure 4. Interventional Features
 Figure 5. Observational Features
 Figure 6. Expanded Access Features
 Figure 7. Others Features
 Figure 8. Global Intelligent Clinical Trials Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Intelligent Clinical Trials Market Share by Application: 2024 VS 2031
 Figure 10. Autoimmune/Inflammation Case Studies
 Figure 11. Pain Management Case Studies
 Figure 12. Oncology Case Studies
 Figure 13. Central Nervous System (CNS) Condition Case Studies
 Figure 14. Diabetes Case Studies
 Figure 15. Obesity Case Studies
 Figure 16. Cardiovascular Case Studies
 Figure 17. Others Case Studies
 Figure 18. Intelligent Clinical Trials Report Years Considered
 Figure 19. Global Intelligent Clinical Trials Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 20. Global Intelligent Clinical Trials Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Intelligent Clinical Trials Market Share by Region: 2024 VS 2031
 Figure 22. Global Intelligent Clinical Trials Market Share by Players in 2024
 Figure 23. Global Top Intelligent Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intelligent Clinical Trials as of 2024)
 Figure 24. The Top 10 and 5 Players Market Share by Intelligent Clinical Trials Revenue in 2024
 Figure 25. North America Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. North America Intelligent Clinical Trials Market Share by Country (2020-2031)
 Figure 27. United States Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Canada Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Intelligent Clinical Trials Market Share by Country (2020-2031)
 Figure 31. Germany Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. France Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. U.K. Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Italy Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Russia Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Nordic Countries Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Intelligent Clinical Trials Market Share by Region (2020-2031)
 Figure 39. China Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Japan Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. South Korea Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. India Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Australia Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Intelligent Clinical Trials Market Share by Country (2020-2031)
 Figure 47. Mexico Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Brazil Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Intelligent Clinical Trials Market Share by Country (2020-2031)
 Figure 51. Turkey Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. UAE Intelligent Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Cerner Corporation Revenue Growth Rate in Intelligent Clinical Trials Business (2020-2025)
 Figure 55. GE Healthcare Revenue Growth Rate in Intelligent Clinical Trials Business (2020-2025)
 Figure 56. Koninklijke Philips N.V. Revenue Growth Rate in Intelligent Clinical Trials Business (2020-2025)
 Figure 57. Cognizant Revenue Growth Rate in Intelligent Clinical Trials Business (2020-2025)
 Figure 58. McKesson Corporation Revenue Growth Rate in Intelligent Clinical Trials Business (2020-2025)
 Figure 59. Athenahealth Revenue Growth Rate in Intelligent Clinical Trials Business (2020-2025)
 Figure 60. Veradigm Revenue Growth Rate in Intelligent Clinical Trials Business (2020-2025)
 Figure 61. Navitas Life Sciences Revenue Growth Rate in Intelligent Clinical Trials Business (2020-2025)
 Figure 62. Medidata Acorn AI Revenue Growth Rate in Intelligent Clinical Trials Business (2020-2025)
 Figure 63. Accenture Revenue Growth Rate in Intelligent Clinical Trials Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global AI In Clinical Trials Market Research Report 2024
Global AI based Clinical Trials Solution Provider Market Research Report 2024
AI based Clinical Trial Solution Market
Global Artificial Intelligence AI in Cancer Market Research Report 2024
Medical AI Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Artificial Intelligence Drug R D Market Research Report 2024
Global AI Technology in Pharmaceutical Market Research Report 2024
Global Artificial Intelligence AI in Drug Discovery Market Insights Forecast to 2030
Artificial Intelligence driven Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Commerce Artificial Intelligence Market Research Report 2024
Global Artificial Intelligence in Medical Market Research Report 2025
Global Artificial Intelligence in Radiology Market Research Report 2024
Global Artificial Intelligence Medical Product Market Research Report 2024
Global AI Clinical Trial Imaging Market Research Report 2024
Global AI Technology in Healthcare Market Research Report 2024
Healthcare Artificial Intelligence Market
Global Artificial Intelligence in Drug Discovery Market Size Status and Forecast 2020 2026
Global AI for Pharma and Biotech Market Insights Forecast to 2030
Global Artificial Intelligence in the Operating Room Market Research Report 2025
Global Artificial Intelligence Based Software for Radiology Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions